๐ฌIn plain words
What the trial is, and whether it could suit you
This is an open-label, randomised, comparative, prospective, interventional study of a cosmetic product.
Sign in to get the eligibility rules as simple questions to take to your doctor.
๐ Eligibility rules (as published)
Inclusion criteria:
Subjects with clinically confirmed mild-to-moderate atopic dermatitis (AD), as defined by an Eczema Area and Severity Index (EASI) score of 1-21, whose lesions will clear after treatment with a steroid and who will experience at least a 90% reduction in their EASI score.
\- Participants of any gender, aged 18 years or over, from any phototype or ethnic group.
Participants must be willing and able to give informed consent to participate in the study.
Exclusion criteria:
* Age \<18 years. Participants who are unwilling or unable to give informed consent to participate in the study.
* Receiving any systemic treatment for atopic dermatitis (AD), including corticosteroids, cyclosporine, any approved biologics or JAK inhibitors.
* Any dermatological disorder which, in the investigator's opinion, may interfere with the accurate evaluation of the subject's skin characteristics (except AD).
๐
What it tests
- CeraVe Moisturizing Cream
- Galenico
Fondazione PTV - Policlinico Tor Vergata
Roma, Italy
๐ค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ always decide together with your own doctor.